HOUSE 2565117th CongressReferred to the Subcommittee on Health.
FDA Modernization Act of 2021
- Last Action
- 4/16/2021
Actions
- 2021-04-16Referred to the Subcommittee on Health.
- 2021-04-15Referred to the House Committee on Energy and Commerce.
- 2021-04-15Introduced in House
- 2021-04-15Introduced in House
CRS Summary
As of 2021-04-15 (00)
FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.
Cosponsors (20)
- Elaine Luria (D-VA)
- Nancy Mace (R-SC)
- Mikie Sherrill (D-NJ)
- Brendan Boyle (D-PA)
- Brian Fitzpatrick (R-PA)
- Tom Cole (R-OK)
- Pat Fallon (R-TX)
- Maria Salazar (R-FL)
- ROSA DELAURO (D-CT)
- Mike Quigley (D-IL)
- PETER DEFAZIO (D-OR)
- Ted Lieu (D-CA)
- Barry Moore (R-AL)
- Earl Carter (R-GA)
- Lizzie Fletcher (D-TX)
- Tim Burchett (R-TN)
- Josh Gottheimer (D-NJ)
- Diana Harshbarger (R-TN)
- Glenn Grothman (R-WI)
- John Katko (R-NY)
Subjects
- Animal protection and human-animal relationships
- Cell biology and embryology
- Computers and information technology
- Drug safety, medical device, and laboratory regulation
- Medical research
- Medical tests and diagnostic methods
- Research and development
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.